You are here

home  ›  news & media  ›  early clinical trial success for rheumatoid arthritis treatment
Publish Date: 
Thursday, June 4, 2015 - 10:30

Early clinical trial success for new rheumatoid arthritis treatment

Yesterday, the University of Queensland Diamantina Institute announced the development of a world-first treatment for rheumatoid arthritis, a debilitating disease which impacts more than 450,000 people in Australia. 

UQ Diamantina Institute researcher Professor Ranjeny Thomas said results from the phase one clinical trial, published in Science Translational Medicine today, demonstrate the new treatment is safe and effective in supressing the immune response.

Media Articles

> Click to read the ABC News article "Breakthrough arthritis treatment developed by University of Queensland researchers"
> Click here to read ABC The World Today "Queensland researchers develop world-first vaccine-style treatment for rheumatoid arthritis"
> Click to read the UQDI article "Early clinical trial success for new rheumatoid arthritis treatment"
> Click to read the Science Translational Medicine journal article "Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype–positive rheumatoid arthritis patients" 
> Click to read the Courier Mail article "Researchers hope world-first therapy for rheumatoid arthritis can lead to treatments for other illnesses"
> Click to watch the Interview with Ranjeny Thomas on Channel 9's Today program
> Click to read the Drug, Discovery & Development article "Early Clinical Trial Success for New RA Treatment"
Also look for these pieces in your local media:
  • 04 Jun 2015 | Rheumatoid arthritis breakthrough | Gold Coast Bulletin by Janelle Miles |  General News - page 9
  • 04 Jun 2015 5:32AM | University of Qld researchers have developed a world-first therapy | 612 ABC Brisbane, Brisbane
  • 04 Jun 2015 10:03AM | Researchers at the University of Queensland have developed a new ... | 666 ABC Canberra, Canberra
  • 04 Jun 2015 6:33AM | University of Queensland researchers have developed a new vaccine | ABC Southern Queensland, Toowoomba

RHEUMATOID ARTHRITIS CLINICAL TRIAL

  • For more information about clinical trials, contact [email protected]
  • Media contact: UQ Diamantina Institute Communications and Marketing Manager Kate Templeman,  +61 7 3443 7027, +61 (0)409 916 801; [email protected]